Filana Therapeutics Statistics
NASDAQ: FLNAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.8045-0.0112 (-1.37%)
Market open · Delayed 15 min · as of Oct 8, 2:57 PM ET
Filana Therapeutics by the numbers
Filana Therapeutics has a market capitalization of $38.9 million based on 48.31M shares outstanding. With trailing EPS of $-0.87, Filana Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 8.8% below its 50-day average and 45.6% below its 200-day average.
Average daily trading volume is 2.03M shares, or about $1.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
FLNA valuation vs. peer median
| Metric | FLNA | Peer median | Difference |
|---|---|---|---|
| Market cap | $38.86M | $41.17M | -6% |
| Avg. volume | 2.03M | 207.21K | +877% |
Peer median across 8 companies: IXHL, VERU, CPHI, IBO, SCYX, GRCE, LITS, NSRX.
Valuation
- Market cap
- $38.86M
- EPS (TTM)
- $-0.87
- Shares outstanding
- 48.31M
Price and trading
- Previous close
- 0.8157
- Open
- 0.8016
- Day range
- 0.775 – 0.8079
- 52-week range
- 0.67 – 4.98
- 52-week change
- -76.15%
- 50-day moving average
- 0.8824
- Beta
- —
- Volume
- 289.31K
- Average volume
- 2.03M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Jul 29, 2026
Additional statistics
- Market Cap
- 38.86M
- Eps
- -0.87
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 4.98
- Week52 Low
- 0.67
- Avg Volume
- 2.03M
- Shares Outstanding
- 48.31M
- Ma50
- 0.88
- Ma200
- 1.48
- Earnings Date
- Jul 29, 2026
- Pct From52w High
- -83.85%
- Pct From52w Low
- 20.07%